Mupirocine Arrow (Mupirocin)

Mupirocine Arrow is a topical antibacterial that targets Gram‑positive skin pathogens. It is indicated for the following conditions:

• Impetigo: eradicates Staphylococcus aureus and Streptococcus pyogenes, reducing lesions and contagion.
• Secondary bacterial skin infections: controls bacterial overgrowth in compromised skin, promoting healing.
• Folliculitis: eliminates the causative bacteria, decreasing inflammation and pustule formation.
• Erysipelas: treats early‑stage infection, limiting spread and systemic involvement.

• Mupirocin inhibits bacterial isoleucyl‑tRNA synthetase, an enzyme essential for protein synthesis. By blocking the attachment of isoleucine to its tRNA, the drug prevents the formation of new proteins, leading to bacterial growth arrest and cell death, primarily against Gram‑positive organisms such as Staphylococcus and Streptococcus species.

Mupirocine Arrow may cause local and systemic reactions.

Common Side Effects

• Burning sensation: mild irritation at the application site.
• Itching: transient pruritus.
• Redness: erythema around the treated area.
• Dryness: skin becomes flaky or scaly.
• Mild pain: discomfort during application.

Serious or Rare Side Effects

• Contact dermatitis: severe allergic skin reaction.
• Skin ulceration: breakdown of epidermis.
• Systemic hypersensitivity: rash, fever, or swelling.
• Secondary infection: overgrowth of resistant organisms.
• Anaphylaxis: rare life‑threatening allergic response.

Before using Mupirocine Arrow, consider the following precautions:

• Allergy assessment: avoid if known hypersensitivity to mupirocin or formulation components.
• Wound type: do not apply to deep puncture wounds or extensive burns without medical advice.
• Duration of therapy: limit use to the prescribed period to reduce resistance risk.
• Pediatric use: follow prescriber guidance for children; safety data are limited.
• Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Mupirocine Arrow has limited systemic absorption, but interactions may still occur.

Major Interactions (Avoid)

• Systemic antibiotics: concurrent use of oral or parenteral antibiotics with overlapping spectra may promote resistance.
• Antifungal creams: may reduce efficacy when applied to the same site.

Moderate Interactions (Monitor Closely)

• Topical steroids: can mask signs of infection, requiring close monitoring.
• Occlusive dressings: increase absorption, potentially enhancing local irritation.
• Other topical agents: assess for additive skin irritation when layered.